Trial Profile
Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Mar 2018
Price :
$35
*
At a glance
- Drugs Ertapenem (Primary) ; Imipenem (Primary)
- Indications Gram-negative infections
- Focus Therapeutic Use
- Acronyms ERIC
- 13 Jun 2014 Status changed from active, no longer recruiting to completed as per ClinicalTrails.gov record.
- 08 Jan 2014 Status changed from recruiting to active, no longer recruiting as per ClinicalTrails.gov
- 26 Oct 2012 New trial record